Cancer cells use elevated glutathione (GSH) levels as an inner line of defense to evade apoptosis and develop drug resistance.Inthis study,wedescribe anovel 2,4-nitrobenzenesulfonyl (DNS) protected 2-hydroxyisophthalamide system that exploits GSH for its activation into free 2-hydroxyisophthalamide forming supramolecular M + /Cl À channels.Better permeation of the DNS protected compound into MCF-7 cells compared to the free 2-hydroxyisophthalamide and GSHactivatable ion transport resulted in higher cytotoxicity,w hich was associated with increased oxidative stress that further reduced the intracellular GSH levels and altered mitochondrial membrane permeability leading to the induction of the intrinsic apoptosis pathway.T he GSH-activatable transport-mediated cell death was further validated in rat insulinoma cells (INS-1E);w herein the intracellular GSH levels showed ad irect correlation to the resulting cytotoxicity.L astly,t he active compound was found to restrict the growth and proliferation of 3D spheroids of MCF-7 cells with efficiency similar to that of the anticancer drug doxorubicin.Supportinginformation and the ORCID identification number(s) for the author(s) of this article can be found under https://doi.
Cancer cells use elevated glutathione (GSH) levels as an inner line of defense to evade apoptosis and develop drug resistance. In this study, we describe a novel 2,4‐nitrobenzenesulfonyl (DNS) protected 2‐hydroxyisophthalamide system that exploits GSH for its activation into free 2‐hydroxyisophthalamide forming supramolecular M+/Cl− channels. Better permeation of the DNS protected compound into MCF‐7 cells compared to the free 2‐hydroxyisophthalamide and GSH‐activatable ion transport resulted in higher cytotoxicity, which was associated with increased oxidative stress that further reduced the intracellular GSH levels and altered mitochondrial membrane permeability leading to the induction of the intrinsic apoptosis pathway. The GSH‐activatable transport‐mediated cell death was further validated in rat insulinoma cells (INS‐1E); wherein the intracellular GSH levels showed a direct correlation to the resulting cytotoxicity. Lastly, the active compound was found to restrict the growth and proliferation of 3D spheroids of MCF‐7 cells with efficiency similar to that of the anticancer drug doxorubicin.
Multifunctional organic luminogens
exhibiting simultaneous aggregation
induced emission (AIE), room-temperature phosphorescence (RTP), and
mechanochromism have recently attracted considerable attention owing
to their potential applications in optoelectronics and bioimaging.
However, a comprehensive correlation among these three distinguished
properties is yet to be unveiled, which will help to decipher defined
methodologies to design future generation multifunctional organic
materials. Herein, we have demonstrated a route to obtain a multifunctional
organic luminogen, starting from an ACQphore (TPANDI) by simple structural
engineering. We have shown that a slight reduction in length of the
planar acceptor moieties can effectively inhibit the undesirable π–π
stacking interaction between molecules in the condensed state and
thereby cause an ACQ to AIE type transformation from TPANDI to TPANMI
and TPAPMI. Both TPANMI and TPAPMI exhibit RTP properties (even in
ambient condition) because of the presence of a reasonably low singlet–triplet
energy gap (ΔE
ST). In our study,
these two luminogens were found to be mechano-inactive. Interestingly,
an insertion of cyano-ethylene group and benzene linker in between
the triphenylamine and phthalimide moieties introduced another luminogen
TPACNPMI, which can simultaneously exhibit AIE, RTP, and mechanochromic
properties.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.